Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
Summit History
21st Bioshares Biotech Summit
Contact
Contact Us
Email Alerts
Home
>
Premium Biotech Coverage
>
Current News
Current News
Categories
Categories
Acrux
Actinogen (ACW)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Ceretas
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Cynata Therapeutics
Dimerix (DXB)
Imugene (IMU)
Neuren Pharmaceuticals (NEU)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
May 19th, 2024
Blinklab Partners with Autism Foundation for Pre-Registration Study
Read More
April 19th, 2024
IPO Preview – Blinklab
Read More
January 4th, 2024
Top Six Picks for 2024 (Dimerix; ASX = DXB)
Read More
January 4th, 2024
Impressive Results from Neuren's NNZ-2591 Phase II Clinical Trial in Phelan- McDermid Syndrome
Read More
December 12th, 2023
Investor Interest Starts Return to Biotech Sector (Clinuvel)
Read More
December 12th, 2023
Investor Interest Starts Return to Biotech Sector (Dimerix)
Read More
December 12th, 2023
Investor Interest Starts Return to Biotech Sector (Imugene)
Read More
December 12th, 2023
Investor Interest Starts Return to Biotech Sector (Neuren)
Read More
November 20th, 2023
Neuren Completes First of Four Phase II Studies
Read More
November 20th, 2023
Adalta Finalises Data for Licensing with Lead Compound AD214
Read More
Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
